Skip to content
10-Q

Quarterly Report

Tempest Therapeutics, Inc. TPST

0001193125-25-265946

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 30, 2025 4.44M sh
Shares Diluted Q3 2025 · Sep 30, 2025 4.44M sh
Shares Diluted Q3 2025 · Sep 30, 2025 3.9M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 1.99M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 1.81M sh
Capex Q3 2025 · Sep 30, 2025 $0
Capex Q3 2025 · Sep 30, 2024 $432K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$23.25M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$22.88M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $7.51M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $30.27M
Stockholders Equity Q3 2025 · Sep 30, 2025 $6.35M
Stockholders Equity Q3 2025 · Jun 30, 2025 $9.78M
Stockholders Equity Q3 2025 · Mar 31, 2025 $11.13M
Stockholders Equity Q3 2025 · Dec 31, 2024 $19.13M
Stockholders Equity Q3 2025 · Sep 30, 2024 $11.46M
Stockholders Equity Q3 2025 · Jun 30, 2024 $16.94M
Stockholders Equity Q3 2025 · Mar 31, 2024 $20.63M
Stockholders Equity Q3 2025 · Dec 31, 2023 $26.77M
Current Liabilities Q3 2025 · Sep 30, 2025 $3.53M
Current Liabilities Q3 2025 · Dec 31, 2024 $14.22M
Total Liabilities Q3 2025 · Sep 30, 2025 $10.78M
Total Liabilities Q3 2025 · Dec 31, 2024 $22.36M
Current Assets Q3 2025 · Sep 30, 2025 $8.1M
Current Assets Q3 2025 · Dec 31, 2024 $31.47M
Total Assets Q3 2025 · Sep 30, 2025 $17.13M
Total Assets Q3 2025 · Dec 31, 2024 $41.49M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.79
Eps Diluted Q3 2025 · Sep 30, 2025 −$5.71
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$5.32
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$15.48
Eps Basic Q3 2025 · Sep 30, 2025 −$0.79
Eps Basic Q3 2025 · Sep 30, 2025 −$5.71
Eps Basic restated Q3 2025 · Sep 30, 2024 −$5.32
Eps Basic restated Q3 2025 · Sep 30, 2024 −$15.48
Net Income Q3 2025 · Sep 30, 2025 −$3.51M
Net Income Q3 2025 · Sep 30, 2025 −$22.24M
Net Income Q3 2025 · Jun 30, 2025 −$7.87M
Net Income Q3 2025 · Mar 31, 2025 −$10.86M
Net Income Q3 2025 · Sep 30, 2024 −$10.56M
Net Income Q3 2025 · Sep 30, 2024 −$28.03M
Net Income Q3 2025 · Jun 30, 2024 −$9.57M
Net Income Q3 2025 · Mar 31, 2024 −$7.9M
Operating Income Q3 2025 · Sep 30, 2025 −$3.6M
Operating Income Q3 2025 · Sep 30, 2025 −$22.5M
Operating Income Q3 2025 · Sep 30, 2024 −$10.55M
Operating Income Q3 2025 · Sep 30, 2024 −$28.11M